Welcome to the e-CCO Library!

P454: Can calcineurin inhibitors induce a durable remission that is maintained with vedolizumab in IBD?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kassim O.1, Micic D.2, Christensen B.1, Pekow J.1, Sakuraba A.1, Dalal S.1, Rubin D.1, Cohen R.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P454: Combo-therapy in infliximab-resistant inflammatory bowel disease patients: data from a tertiary referral centre
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Renna*, G. Rizzuto, E. Orlando, M. Affronti, M. Cottone, A. Orlando

Created: Friday, 22 February 2019, 9:49 AM
P454: Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

W. Yacoub1, N. Williet2, L. Pouillon1,3*, T. Di-Bernado2, M. De Carvalho Bittencourt4, S. Nancey5, A. Lopez1, S. Paul6, C. Zallot1, X. Roblin2, L. Peyrin-Biroulet1

Created: Thursday, 21 February 2019, 9:14 AM
P454: Evaluation of the nutritional care status in italian centers managing patients affected by inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Saibeni, S.(1);Bezzio , C.(1);Armuzzi, A.(2);Daperno, M.(3);Zanetti, M.(4);Vernero, M.(5); Giorgetti, G.M.(6);
Created: Friday, 11 February 2022, 3:52 PM
P454: No increased postoperative risk of venous thromboembolism nor infectious complications after JAK inhibitor exposure in patients with ulcerative colitis undergoing colectomy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: De Greef, I.(1)*;Bislenghi, G.(2);Terrasson, I.(2);Sabino, J.(1);Ferrante, M.(1);D'Hoore, A.(2);Vermeire, S.(1);Verstockt, B.(1);
Created: Friday, 14 July 2023, 11:05 AM
P454: Prediction of endoscopic activity in patients with Crohn’s disease: systematic review and external validation of published prediction models
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. C. Brand*1,2, S. G. Elias3, I. M. Minderhoud4, J. J. van der Veen1, F. Baert5, D. Laharie6, P. Bossuyt7, Y. Bouhnik8, A. Buisson9, G. Lambrecht10, E. Louis11, B. Pariente12, M. J. Pierik13, C. J. van der Woude14, G. R. D'Haens15, S. Vermeire16, B. Oldenburg1

Created: Friday, 22 February 2019, 9:41 AM
P454: Treatment with biologics improves disability from Inflammatory Bowel Disease in therapy responders
Year: 2021
Source: ECCO'21 Virtual
Authors: Castillo, G.(1);Sultan, K.(2);Kwah, J.(3);Chen, L.A.(4);Axelrad, J.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P455 Adherence to enteral nutrition therapy by adults with active Crohn’s disease is associated with conscientiousness personality trait
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Wall1, A. McCombie2, R. Mulder3, A. Day4, R. Gearry1

Created: Thursday, 30 January 2020, 10:12 AM
P455: Aminosalicylates in Ulcerative Colitis: old but gold?
Year: 2022
Source: ECCO'22
Authors: Sequeira, C.(1);Santos, I.(1);Coelho, M.(1);Teixeira, C.(1);Mangualde, J.(1);Cremers, I.(1);Oliveira, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P455: Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Estévez-Gil M.1, De Castro M.L.*2, Hernández V.2, Pineda J.R.2, Martínez-Cadilla J.2, Pereira S.2, Rodríguez-Prada J.-I.2

Created: Wednesday, 20 February 2019, 10:36 AM
P455: Comparison of two strategies for the management of post-operative recurrence in Crohn's disease patients with one clinical risk factor: a multicentre IG-IBD study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dragoni, G.(1)*;Castiglione, F.(2);Bezzio, C.(3);Pugliese, D.(4);Spagnuolo, R.(5);Viola, A.(6);Cocomazzi, F.(7);Aratari, A.(8);Savarino, E.V.(9);Balestrieri, P.(10);Onali, S.(11);Viganò, C.(12);Ribaldone, D.G.(13);Innocenti, T.(14);Testa, A.(2);Saibeni, S.(3);Privitera, G.(4);Milla, M.(14);Armuzzi, A.(15);Fantini, M.C.(11);Fiorino, G.(16);
Created: Friday, 14 July 2023, 11:05 AM
P455: Evaluation of the optic nerve function in patients with ulcerative colitis and Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Skamnelos*1, A. Kavvadias1, P. Zafeiropoulos2, K. Katsanos1, I. Asproudis2, D. Christodoulou1

Created: Friday, 22 February 2019, 9:41 AM
P455: Spacing of infliximab infusions over 8 weeks in patients with inflammatory bowel diseases in clinical remission: Final results of a retrospective multicentre French national cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Dufour1*, B. Pariente2, A. Amiot3, S. Viennot4, F. Zerbib5, L. Caillo6, S. Nancey7, P. Pouderoux6, F. Poullenot5, R. Altwegg1, L. Peyrin-Biroulet8, M. Nachury2, P. Blanc1, G. Pineton de Chambrun1

Created: Thursday, 21 February 2019, 9:14 AM
P455: The effect of concurrent HIV-1 infection on the management of patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. H. Ho, R. Fausel, J. Torres, J. J. Yang, T. H. Swartz, J. A. Aberg, J.-F. Colombel, S. Mehandru*

Created: Friday, 22 February 2019, 9:49 AM
P455: Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Silfen, A.(1);Cohen, N.(1);Traboulsi, C.(1);Rodriguez, T.(1);Steinberg, J.(1);Singer, J.(1);Patel, S.(1);Cohen, R.(1);Dalal, S.(1);Micic, D.(1);Pekow, J.(1);Sakuraba, A.(1);Rubin, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P456 Longer-term outcomes in acute severe colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. CAMPBELL, R. Haddock, K. Parman, J. MacDonald, J.P. Seenan

Created: Thursday, 30 January 2020, 10:12 AM
P456: Comparative analysis of oral versus intravenous iron in patients with inflammatory bowel disease and iron deficiency/anaemia – impact on hospitalisation in Germany
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Borchert K.1, Hardt T.2, Haas J.S.1, Ong S.H.3, Lechat E.1, Nip K.2, Foerster D.3, Braun S.1, Stein J.*4,5

Created: Wednesday, 20 February 2019, 10:36 AM
P456: Drug survival of thiopurine–allopurinol combination therapy in a real-life population-based cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.E. Kreijne1*, R.C. de Veer1, N.K. de Boer2, G. Bouma2, G. Dijkstra3, R.L. West4, A.A. van Bodegraven5, D.J. de Jong6, C.J. van der Woude1, A.C. de Vries1

Created: Thursday, 21 February 2019, 9:14 AM
P456: Efficacy and safety of TNF antagonist for the treatment of internal fistulising Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Huguet1, A.-L. Mallet1, V. Desfourneaux1, L. Siproudhis1, J.-F. Bretagne2, G. Bouguen*2

Created: Friday, 22 February 2019, 9:49 AM
P456: Ig glycosylation in ulcerative colitis: it's time for new biomarkers
Year: 2021
Source: ECCO'21 Virtual
Authors: Capecchi, R.(1);Migliorini, P.(1);Zanzi, F.(1);Maltinti, S.(1);Puxeddu, I.(1);De Bortoli, N.(1);Bellini, M.(1);Costa, F.(2);Marchi, S.(1);Bertani, L.(1);
Created: Wednesday, 2 June 2021, 4:12 PM